BD BBL™ SENSI-DISC™ CEFPODOXIME 10 ΜG - COFEPRIS Registration 2486R2018 SSA
Access comprehensive regulatory information for BD BBL™ SENSI-DISC™ CEFPODOXIME 10 ΜG (BD BBL™ SENSI-DISC™ CEFPODOXIME 10 ΜG) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 2486R2018 SSA and manufactured by BECTON DICKINSON DE MÉXICO, S.A. DE C.V.. The device was registered on October 29, 2018.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
PARA REALIZAR PRUEBAS SEMICUANTITATIVAS DE SENSIBILIDAD IN VITRO, DE PATÓGENOS BACTERIANOS, POR MEDIO DEL PROCEDIMIENTO DE PRUEBA DE DIFUSIÓN DE DISCO EN AGAR. AGENTE DE DIAGNÓSTICO PARA USO IN VITRO. PARA USO EXCLUSIVO DE LABORATORIOS CLÍNICOS O DE GAB
TO PERFORM SEMIQUANTITATIVE IN VITRO SENSITIVITY TESTS OF BACTERIAL PATHOGENS BY MEANS OF THE AGAR DISC DIFFUSION TEST PROCEDURE. DIAGNOSTIC AGENT FOR IN VITRO USE. FOR USE BY CLINICAL LABORATORIES OR GAB ONLY.